Recently, the selective P2X7 receptor antagonist A-740003 was reported to significantly attenuate the NLRP3 inflammasome upregulation and decrease the mean right ventricular (RV) pressure and RV hypertrophy associated with pulmonary hypertension [123]. This evidence concerns the gene NLRP3 and pulmonary hypertension.